U.S. Markets open in 4 hrs 39 mins
  • S&P Futures

    3,255.75
    -46.50 (-1.41%)
     
  • Dow Futures

    26,182.00
    -375.00 (-1.41%)
     
  • Nasdaq Futures

    11,125.25
    -217.50 (-1.92%)
     
  • Russell 2000 Futures

    1,541.90
    -16.50 (-1.06%)
     
  • Crude Oil

    36.22
    +0.05 (+0.14%)
     
  • Gold

    1,870.50
    +2.50 (+0.13%)
     
  • Silver

    23.36
    0.00 (0.00%)
     
  • EUR/USD

    1.1669
    -0.0010 (-0.0817%)
     
  • 10-Yr Bond

    0.8350
    0.0000 (0.00%)
     
  • Vix

    39.16
    -1.12 (-2.78%)
     
  • GBP/USD

    1.2917
    -0.0007 (-0.0517%)
     
  • USD/JPY

    104.4090
    -0.2010 (-0.1921%)
     
  • BTC-USD

    13,257.45
    -116.73 (-0.87%)
     
  • CMC Crypto 200

    259.69
    +17.01 (+7.01%)
     
  • FTSE 100

    5,577.62
    -4.13 (-0.07%)
     
  • Nikkei 225

    22,977.13
    -354.81 (-1.52%)
     

ALERT: Halper Sadeh LLP Reminds Investors About Its Ongoing Investigations; Shareholders are Encouraged to Contact the Firm – BDGE, CBMG, CGIX, BMCH

·3 mins read

NEW YORK, NY / ACCESSWIRE / September 24, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating:

Bridge Bancorp, Inc. (NASDAQ:BDGE) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Dime Community Bancshares, Inc. Under the terms of the merger, Dime Community shareholders will receive 0.6480 shares of Bridge Bancorp common stock for each share of Dime Community common stock they own. Visit our website to learn more about your legal rights and options: https://halpersadeh.com/actions/bridge-bancorp-inc-bdge-stock-merger-dime-community/.

Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to a consortium that includes members of Cellular Biomedicine management and several entities. Under the terms of the merger, Cellular Biomedicine stockholders (excluding certain parties) will receive $19.75 in cash for each outstanding share of common stock held immediately prior to the effective time of the merger. Visit our website to learn more about your legal rights and options: https://halpersadeh.com/actions/cellular-biomedicine-group-inc-cbmg-stock-merger/.

Cancer Genetics, Inc. (NASDAQ:CGIX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with StemoniX, Inc. Under the merger agreement, Cancer Genetics will acquire all of the outstanding capital stock of StemoniX in exchange for a number of shares of its common stock, with current equity holders of Cancer Genetics expected to own 22% of the common stock of the combined company. Visit our website to learn more about your legal rights and options: https://halpersadeh.com/actions/cancer-genetics-inc-cgix-stock-merger-stemonix/.

BMC Stock Holdings, Inc. (NASDAQ:BMCH) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Builders FirstSource, Inc. Under the terms of the agreement, BMC shareholders will receive 1.3125 shares of Builders FirstSource common stock for each share of BMC common stock. Visit our website to learn more about your legal rights and options: https://halpersadeh.com/actions/bmc-stock-holdings-inc-bmch-stock-merger-builders-firstsource/.

Halper Sadeh LLP may seek increased consideration, additional disclosures, and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP



View source version on accesswire.com:
https://www.accesswire.com/607743/ALERT-Halper-Sadeh-LLP-Reminds-Investors-About-Its-Ongoing-Investigations-Shareholders-are-Encouraged-to-Contact-the-Firm-BDGE-CBMG-CGIX-BMCH